Clinical Trials Sponsored by Japan Clinical Oncology Group

Total 238 results

Kyorin University
Japan Clinical Oncology Group

Recruiting

Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III (RE-GEND)

Recurrence | Glioblastoma | Progression

Japan
Japan Liver Oncology Group

Unknown

Sonazoid Enhanced Liver Cancer Trial for Early Detection

Liver Cirrhosis | Hepatitis B | Hepatocellular Carcinoma | Hepatitis C

Japan
Japan Liver Oncology Group

Unknown

Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease (FIBROELAST)

Chronic Hepatitis B | Chronic Hepatitis C

Japan
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Completed

A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer

Gastric Neoplasm

Japan
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Terminated

A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma

Carcinoma, Squamous Cell | Esophageal Neoplasms

Japan
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Completed

Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2)

Gastric Neoplasm

Japan
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Completed

A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)

Lymphoma | Adult T-cell Leukemia

Japan
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Terminated

Elderly NSCLC/D vs DP (JCOG0207)

Non-small-cell Lung Cancer

Japan
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Completed

A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer

Breast Cancer | Neoplasm Metastasis

Japan
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Terminated

Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)

Non-Hodgkin's Lymphoma

Japan
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Completed

Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)

Non-Small-Cell Lung Carcinoma

Japan
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Completed

A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis

Neoplasm Metastasis | Gastric Cancer

Japan
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Completed

Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion

Malignant Pericardial Effusion

Japan
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Completed

Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806)

Pulmonary Neoplasm

Japan
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Completed

OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206

Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms

Japan
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Terminated

Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)

Gastric Neoplasm

Japan
West Japan Thoracic Oncology Group

Completed

Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Lung Cancer
West Japan Thoracic Oncology Group

Unknown

Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer

Lung Cancer

Japan
West Japan Thoracic Oncology Group

Completed

A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer

Lung Cancer
West Japan Thoracic Oncology Group

Completed

A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer

Lung Cancer
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer

Gastric Neoplasm

Japan
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110

Gastric Neoplasm

Japan
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC)

Pulmonary Neoplasms

Japan
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

A Trial of Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy for Metastasis

Neoplasm Metastasis | Brain Neoplasms

Japan
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)

Uterine Cervical Neoplasms

Japan
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC

Small-Cell-Lung Cancer

Japan
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

A Trial to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer

Colorectal Cancer

Japan
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)

Lymphoma, B-Cell

Japan
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy

Prostate Cancer

Japan
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)

Rectal Neoplasms

Japan
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)

T1N0M0 Non-small Cell Lung Cancer

Japan
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)

Colorectal Neoplasms

Japan
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Terminated

A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer

Cervical Neoplasms

Japan
National Cancer Center Hospital East
Japan Agency for Medical Research and Development; Japan Clinical Oncology...

Recruiting

Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer (JCOG1801)

Rectal Cancer Recurrent

Japan
Ontario Clinical Oncology Group (OCOG)

Recruiting

Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy (ROSALIE)

Breast Cancer

Canada
Ontario Clinical Oncology Group (OCOG)

Recruiting

A Randomized Trial of Five Fraction Partial Breast Irradiation

Breast Neoplasm Female | Radiotherapy | Cosmetic Outcome

Canada
Ontario Clinical Oncology Group (OCOG)
NCIC Clinical Trials Group

Completed

Shorter Radiation Schedule for the Treatment of Prostate Cancer

Prostate Cancer

Canada
National Cancer Center Hospital East
AstraZeneca; Japan Agency for Medical Research and Development; Japan Clinical...

Not yet recruiting

Efficacy and Safety of CRT, Durvalumab and Surgery for SST (DEEP_OCEAN)

Non Small Cell Lung Cancer Stage III | Superior Sulcus Tumor | Non-small Cell Lung Cancer Stage IIB
Ontario Clinical Oncology Group (OCOG)

Recruiting

Hypofractionated LocoRegional Radiotherapy in Breast Cancer (RHEAL)

Breast Neoplasms | Lymphedema | Radiotherapy

Canada
Ontario Clinical Oncology Group (OCOG)

Completed

Assessment of New Molecular Imaging Strategies for Prostate Cancer (MISTER)

Prostate Cancer

Canada
Ontario Clinical Oncology Group (OCOG)

Completed

Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS (DUCHESS)

DCIS

Canada
Ontario Clinical Oncology Group (OCOG)

Completed

Study To Investigate the Feasibility and Safety of A Dedicated High Resolution Nuclear Breast Imaging Camera (THORN)

Breast Cancer

Canada
Ontario Clinical Oncology Group (OCOG)

Recruiting

Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS) (ELISA)

DCIS

Canada
Ontario Clinical Oncology Group (OCOG)

Terminated

Imaging With 111 Indium (111In)-Pertuzumab (PmAb) to Predict Response to Trastuzumab (TmAb) in Human Epidermal Growth Factor-2 (HER2) Positive Metastatic Breast Cancer (MBC) or Locally Advanced Breast Cancer (LABC) (PETRA)

Breast Cancer

Canada
Ontario Clinical Oncology Group (OCOG)

Completed

Hypofractionated Radiotherapy Post-Lumpectomy in Women With Node Negative Breast Cancer

Breast Cancer

Canada
Ontario Clinical Oncology Group (OCOG)

Completed

Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) and Fluorothymidine Positron Emission Tomography (FLT PET) in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy (IMPACT)

Locally Advanced Breast Cancer (LABC)

Canada
Ontario Clinical Oncology Group (OCOG)

Completed

Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate

Prostate Cancer

Canada
Ontario Clinical Oncology Group (OCOG)
Pfizer

Not yet recruiting

Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma (EMBRACE)

Refractory Multiple Myeloma

Canada
Ontario Clinical Oncology Group (OCOG)
Pfizer

Completed

Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

Ovarian Cancer

Canada
Ontario Clinical Oncology Group (OCOG)
AstraZeneca

Completed

Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy (ELAAT)

Prostate Cancer

Canada

Clinical Trials Sponsored by Japan Clinical Oncology Group

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations